The NPHS1 gene plays a crucial role in kidney function, and mutations in this gene are associated with Nephrotic Syndrome Type 2, a genetic disorder characterized by significant proteinuria, hypoalbuminemia, and edema. This condition can lead to severe kidney damage and failure if not diagnosed and managed appropriately. The genetic test for NPHS1 gene mutations is a crucial tool in the diagnosis and management of Nephrotic Syndrome Type 2. It helps in identifying the genetic cause of the condition, enabling personalized treatment plans and informing family planning decisions.
DNA Labs UAE offers a comprehensive genetic test for the NPHS1 gene to identify mutations associated with Nephrotic Syndrome Type 2. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately detect and interpret genetic variations. Conducted in a state-of-the-art laboratory by experienced geneticists, the test involves analyzing the patient's DNA sample, usually obtained through a simple blood draw. Results from this test can provide valuable insights into the genetic basis of the condition, guiding treatment options and helping to predict the risk of passing the condition to future generations.
The PLCE1 Gene Nephrotic Syndrome Type 3 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the PLCE1 gene, which are associated with Nephrotic Syndrome Type 3. This condition, also known as familial steroid-resistant nephrotic syndrome, is characterized by significant proteinuria, hypoalbuminemia, hyperlipidemia, and edema. It is a rare genetic disorder that affects the kidneys' filtering system, leading to a loss of protein in the urine and reduced ability to regulate water and salt levels in the body.
The test is conducted at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the test is 4400 AED. This investment in testing is crucial for families with a history of the condition or for individuals showing symptoms of nephrotic syndrome, as early detection can significantly influence the management and treatment options for affected individuals. The results from this genetic test can provide valuable information for healthcare providers to develop a personalized treatment plan, potentially involving medication, dietary adjustments, and in some cases, consideration of genetic counseling for the family.
Understanding the genetic basis of Nephrotic Syndrome Type 3 through the PLCE1 gene test is an essential step in advancing patient care and improving outcomes for those affected by this challenging condition.
The LAMB2 Gene Nephrotic Syndrome Type 5 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the LAMB2 gene, which are associated with Nephrotic Syndrome Type 5. This condition is a rare genetic disorder characterized by significant proteinuria, hypoalbuminemia, and edema. Mutations in the LAMB2 gene can lead to alterations in the production or function of the laminin β2 protein, which plays a crucial role in the structure and function of the kidney's glomerular basement membrane. Early detection through this genetic test can aid in the proper management and treatment of the condition, potentially preventing further kidney damage and improving patient outcomes. The test is priced at 4400 AED and is conducted with state-of-the-art technology to ensure high accuracy and reliability of results. DNA Labs UAE provides this service as part of its commitment to offering advanced genetic testing solutions to diagnose a wide range of inherited disorders.
The DGKE Gene Nephrotic Syndrome Type 7 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the DGKE gene, which are known to cause Nephrotic Syndrome Type 7. This condition is a rare form of nephrotic syndrome, characterized by significant proteinuria, hypoalbuminemia, and edema, and it is particularly noted for its resistance to standard steroid treatments, making genetic identification crucial for appropriate management and treatment planning.
Performed at DNA Labs UAE, a facility renowned for its advanced genetic testing capabilities, this test is an important tool for clinicians in the diagnosis and management of patients suspected to have this genetic form of nephrotic syndrome. The test cost is set at 4400 AED, reflecting the comprehensive analysis involved in identifying the specific mutations within the DGKE gene.
By opting for this genetic test, healthcare providers can make informed decisions regarding the most effective treatment strategies for affected individuals, potentially guiding them towards alternative therapeutic options that are more suited to their specific genetic makeup. This not only enhances the quality of care but also offers hope for better clinical outcomes for patients with this challenging condition.
The ATP7A Gene Menkes Disease Genetic Test is a critical diagnostic tool used to identify mutations in the ATP7A gene, which are responsible for Menkes Disease. This condition, also known as Menkes kinky hair syndrome, is a genetic disorder that affects copper levels in the body, leading to severe developmental issues, neurological problems, and a characteristic appearance of brittle, kinky hair. Early detection through genetic testing is vital for the management and treatment of this disorder.
The test specifically looks for mutations in the ATP7A gene, which plays a key role in the regulation of copper transport and metabolism. A mutation in this gene disrupts the normal functioning of copper in the body, leading to the symptoms associated with Menkes Disease.
Offered by DNA Labs UAE, the ATP7A Gene Menkes Disease Genetic Test is conducted through a comprehensive analysis of the patient's DNA, extracted from a blood sample. This advanced genetic testing helps in confirming the diagnosis, enabling early intervention strategies that can significantly improve the quality of life for affected individuals.
The cost of the ATP7A Gene Menkes Disease Genetic Test is 4400 AED. While the price may seem significant, the value of early and accurate diagnosis cannot be overstated, as it opens the door to potential treatments and specialized care that can mitigate the effects of the disease. DNA Labs UAE is known for its commitment to providing accurate, reliable, and timely genetic testing services, making it a trusted choice for this essential test.
The SAMD9 Gene Mirage Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SAMD9 gene. These mutations are associated with MIRAGE Syndrome, a rare genetic disorder characterized by a wide range of clinical features including developmental delays, growth retardation, and various endocrine abnormalities. The test is crucial for early diagnosis and management of the syndrome, offering insights into potential treatments and interventions tailored to the patient's genetic makeup.
Performed at the state-of-the-art facilities of DNA Labs UAE, the test involves collecting a DNA sample, typically through a blood draw, from which the SAMD9 gene is analyzed for any genetic abnormalities indicative of MIRAGE Syndrome. The cost of the test is 4400 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology employed.
This genetic test is a valuable resource for families with a history of MIRAGE Syndrome or for individuals showing symptoms suggestive of the condition, providing them with essential genetic information to guide healthcare decisions.
The MEN1 gene multiple endocrine neoplasia type 1 genetic test is a specialized diagnostic procedure designed to detect mutations in the MEN1 gene, which is linked to multiple endocrine neoplasia type 1 (MEN1). MEN1 is a rare hereditary disorder that predisposes individuals to develop tumors in multiple endocrine glands, including the parathyroid glands, the pituitary gland, and the pancreas. These tumors can be benign or malignant and can lead to a variety of health problems, including hormonal imbalances and endocrine dysfunction.
The test is crucial for individuals with a family history of MEN1 or those who exhibit symptoms associated with the disorder, as early detection can significantly improve management and treatment outcomes. By analyzing DNA samples, usually obtained from blood, the test identifies specific mutations in the MEN1 gene that are responsible for the condition.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the MEN1 gene test offers a reliable means of diagnosing this complex condition. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to accurately interpret the results. Individuals undergoing this test at DNA Labs UAE can expect comprehensive support, from sample collection to result interpretation, ensuring a thorough understanding of their genetic risk and aiding in the development of personalized management plans.
The AVPR2 Gene Nephrogenic Syndrome of Inappropriate Antidiuresis (NSIAD) Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to detect mutations in the AVPR2 gene. This gene is crucial for the normal function of the kidneys in managing water balance within the body. Mutations in the AVPR2 gene can lead to Nephrogenic Syndrome of Inappropriate Antidiuresis (NSIAD), a rare condition characterized by the inability of the kidneys to properly concentrate urine in response to antidiuretic hormone, leading to water retention and hyponatremia (low sodium levels in the blood).
The test, priced at 4400 AED, involves analyzing the patient's DNA to identify any genetic alterations in the AVPR2 gene that may be causing the syndrome. This is crucial for confirming the diagnosis, understanding the disease mechanism, and guiding treatment options. It is particularly recommended for individuals presenting symptoms of NSIAD, such as excessive thirst and urination, or for those with a family history of the condition. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test provides a reliable and accurate diagnosis, aiding clinicians in the management of NSIAD and improving patient outcomes.
The CLCN5 gene nephrolithiasis type 1 genetic test is a specialized diagnostic procedure designed to identify mutations in the CLCN5 gene, which are associated with a specific form of kidney stone disease known as Dent disease type 1. This condition is characterized by the presence of calcium stones in the kidney, along with other potential symptoms such as proteinuria, hypercalciuria, and kidney failure. The test is crucial for individuals showing symptoms of the disease or those with a family history of kidney stones, as early detection can lead to better management and treatment options.
Performed at DNA Labs UAE, the test involves collecting a DNA sample, usually through a blood draw or a cheek swab, and analyzing it for abnormalities in the CLCN5 gene. With a cost of 4400 AED, the test is a valuable tool for healthcare professionals to diagnose Dent disease type 1 accurately, enabling targeted interventions that can significantly improve the quality of life for affected individuals. It is recommended for patients and families seeking clarity on their genetic predisposition to nephrolithiasis type 1, facilitating informed decisions regarding their health management and preventive measures against kidney stones.
The SLC34A1 gene plays a critical role in phosphate homeostasis by encoding a sodium-phosphate co-transporter that is primarily expressed in the kidney. Mutations in this gene can lead to a rare condition known as nephrolithiasis/osteoporosis, hypophosphatemic, type 1 (NPHLOP1). This disorder is characterized by reduced phosphate reabsorption in the kidneys, leading to low levels of phosphate in the blood (hypophosphatemia), which can result in the development of kidney stones (nephrolithiasis) and weakened bones prone to fractures (osteoporosis).
To diagnose this condition, genetic testing of the SLC34A1 gene is essential. DNA Labs UAE offers a comprehensive genetic test for the SLC34A1 gene to identify mutations associated with nephrolithiasis/osteoporosis, hypophosphatemic, type 1. The test is priced at 4400 AED and involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic variations that could lead to the disorder.
This test is particularly important for individuals with a family history of the condition or those exhibiting symptoms, as early detection can facilitate better management and treatment strategies to mitigate the impact of the disease. DNA Labs UAE employs state-of-the-art technology and follows rigorous protocols to ensure the accuracy and reliability of the test results.
